New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease.
about
HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applicationsSphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protectionGenome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study.Correlation of structural stability with functional remodeling of high-density lipoproteins: the importance of being disordered.HDL anti-oxidant function associates with LDL level in young adults.Segregation of LIPG, CETP, and GALNT2 mutations in Caucasian families with extremely high HDL cholesterol.Genetic and structure-function studies of missense mutations in human endothelial lipasePrevalence of persistent lipid abnormalities in statin-treated patients: Belgian results of the Dyslipidaemia International Study (DYSIS).Tristetraprolin-dependent post-transcriptional regulation of inflammatory cytokine mRNA expression by apolipoprotein A-I: role of ATP-binding membrane cassette transporter A1 and signal transducer and activator of transcription 3.A Novel Anti-Inflammatory Effect for High Density Lipoprotein.Serum amyloid A impairs the antiinflammatory properties of HDLAssessment of adiponectin level in obese and lean Nepalese population and its possible correlation with lipid profile: A cross-sectional study.Protein expression profiles distinguish between experimental invasive pulmonary aspergillosis and Pseudomonas pneumonia.Genetic variants influencing circulating lipid levels and risk of coronary artery disease.The role of sphingolipid signalling in diabetes‑associated pathologies (Review).Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy.Overcoming metabolic syndrome in severe obesity: adiponectin as a marker of insulin sensitivity and HDL-cholesterol improvements after gastric bypass.Long-term effects of acute low-dose ionizing radiation on the neonatal mouse heart: a proteomic study.RVX 208: A novel BET protein inhibitor, role as an inducer of apo A-I/HDL and beyond.Synthetic Amphipathic Helical Peptides Targeting CD36 Attenuate Lipopolysaccharide-Induced Inflammation and Acute Lung Injury.Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.Application of mass spectrometry to elucidate the pathophysiology of Encephalitozoon cuniculi infection in rabbits.Depression, obesity, and metabolic syndrome: prevalence and risks of comorbidity in a population-based representative sample of Mexican Americans.ABCA1 and ABCG1 protect against oxidative stress-induced macrophage apoptosis during efferocytosis.Hematopoietic stem/progenitor cell proliferation and differentiation is differentially regulated by high-density and low-density lipoproteins in mice.Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects.ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation.Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib.Total lipid management and cardiovascular disease in the dyslipidemia international study.Prevalence of dyslipidaemia in statin-treated patients in Ireland: Irish results of the DYSlipidaemia International Study (DYSIS).Persistent dyslipidemia in Austrian patients treated with statins for primary and secondary prevention of atherosclerotic events - Results of the DYSlipidemia International Study (DYSIS).Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.Improvement bioavailability of silymarin ameliorates severe dyslipidemia associated with metabolic syndromeGold nanoparticles as cell regulators: beneficial effects of gold nanoparticles on the metabolic profile of mice with pre-existing obesity
P2860
Q26779667-F3D91781-5057-4E9B-ADD4-9F8DDD8888F4Q28235893-39176767-3007-4B0F-80F8-9424E789C216Q30484496-5ED0B5E2-88EE-45C9-9818-20F1D03EBCB4Q33657079-DEA0631E-1706-46A2-A2F9-C3DE0BBCA2DAQ33689682-2956B3D5-C1FF-42B7-8EB7-B9465B874363Q34404589-C3791581-35E4-4BF9-92EF-5C759E72661BQ34638925-1ECCF05A-4DB3-453E-9A10-4BD5F6879C3AQ34693274-4D93E532-7327-485F-9DEC-CE4571FFE1FFQ34799841-CCCD3B34-6AFD-479D-AA51-19C76BF35B7CQ35872393-33F82346-23BB-4491-A8C7-586D369FC6CBQ36430779-2B20F1C4-771D-4011-B358-8C8A8F25CDC9Q37314707-48FB7E8C-7885-46F8-9A3C-BC2C18DC3E0BQ37383763-368D6317-FC3B-4AC9-8895-6D37BE0FBC60Q37477713-2D368F39-5E42-4910-8688-C1F1D6C481DDQ37711953-76A24D2A-5A07-47EA-BBD0-DEE168861C6AQ38124049-AB409334-E767-4120-B66D-988514B402AAQ38353803-BDC033AB-D5DB-47B8-89D3-6B2BCE79EEE6Q38487751-99239927-2B3A-46FD-B338-CE797C643762Q39250736-78C7B99E-74B4-4309-9A3A-D5B59E56EFDCQ39674456-F5498049-8971-4FC7-95C6-F0527543A71BQ39765898-6FFFAB65-AB7B-48F7-883A-0EFF23563629Q40127827-4A6BAA60-782C-47D8-A4B5-0E2B0B01CBA3Q40362288-CC558CC8-64AB-4B89-A49A-BF45167448A8Q41305436-C4B6C087-4D86-4511-B3A2-0C2F05069673Q41374536-3F3C2079-F00B-49D9-8958-6D04EEC1BBC3Q41622735-96C36BB7-318A-4112-87D3-D6F4C4B39E18Q41789790-C5FCBF2B-BB01-4ECA-8A43-3464EAFAF82FQ42143910-56860633-6560-4651-BBC9-89954680BEBBQ42562376-055F6A6D-20E5-4F84-AEFF-D9FA74361A77Q43569682-E36F7FCF-8C92-400C-8CE3-8A7C6D8699A9Q44406831-B1400800-5C1C-44FB-8193-EC0EE9FC7C37Q45189719-8EDBB6A4-7137-4A06-A23A-B78210C663EBQ53099325-6468F18F-D488-42E2-8C68-CEE29E72EB0DQ57652157-3C884523-0CB8-4977-8AD9-58EF5B6F670EQ58614419-3F39982C-4E59-479C-BE88-1A37D9A46211
P2860
New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
New insights into the role of ...... ion of cardiovascular disease.
@en
New insights into the role of ...... ion of cardiovascular disease.
@nl
type
label
New insights into the role of ...... ion of cardiovascular disease.
@en
New insights into the role of ...... ion of cardiovascular disease.
@nl
prefLabel
New insights into the role of ...... ion of cardiovascular disease.
@en
New insights into the role of ...... ion of cardiovascular disease.
@nl
P2093
P2860
P356
P1476
New insights into the role of ...... ion of cardiovascular disease.
@en
P2093
Kerry-Anne Rye
Philip J Barter
Rajesh Puranik
P2860
P2888
P304
P356
10.1007/BF02938394
P577
2007-11-01T00:00:00Z